º´¿ø¼Ò°³

¼­¿ï´ëº´¿øÀÇ Ç³ºÎÇÑ ÀÓ»ó°æÇè

°­ºÏŬ¸®´Ð

±è¾ç·Ä ¿øÀå
¼­¿ïž¸¶À½Å¬¸®´Ð °­ºÏ
±è¾ç·Ä ¿øÀå
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ¹× µ¿´ëÇпø Á¹¾÷
  • ¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ
  • ¼­¿ï´ëÇб³º´¿ø ½Å°æÁ¤½Å°ú ·¹Áö´øÆ®
  • ¼­¿ï´ëÇб³º´¿ø ¼Ò¾ÆÃ»¼Ò³âÁ¤½Å°ú ÀÓ»ó°­»ç
  • ´ëÇÑ ½Å°æÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø
  • ´ëÇÑ ¼Ò¾ÆÃ»¼Ò³âÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø
  • ¼­Ãʱ¸ Çб³º¸°Ç»ç¾÷ - ADHD »çȸ¼º Çâ»ó ÇÁ·Î±×·¥ ÁøÇà
  • ¼­¿ï½Ã Á¾·Î±¸/¼ººÏ±¸/°­ºÏ±¸ Á¤½Åº¸°Ç¼¾ÅÍ Çù¾àÀÇ·á±â°ü
  • ¼­¿ï½Ã ¼ººÏ±³À°Áö¿øÃ» Çù¾àÀÇ·á±â°ü
  • ¼­¿ï°¡Á¤¹ý¿ø ½É¸®»ó´ãÁ¶»çÀü¹®°¡
  • ¿¬±¸ ¹× ÇмúȰµ¿ ¾ÆÀÌÄÜ
    ¿¬±¸ ¹× ÇмúȰµ¿
    1 Pathological Hypersexuality Induced by Dopamine Replacement Therapy in a Patient with Progressive Supranuclear Palsy. J Neuropsychiatry Clin Neurosci 2008 Nov;20:496-497. (ÁÖ ÀúÀÚ)
    2 Á¶±â¹ßº´ Á¤½ÅºÐ¿­º´ ȯ¾Æ¿¡¼­ SPECT·Î ÃøÁ¤ÇÑ ±¹¼Ò ³úÇ÷·ù·® ÀÌ»ó : SPM(Statistical Parametric Mapping) ºÐ¼®, ¼Ò¾ÆÃ»¼Ò³â Á¤½ÅÀÇÇÐ Á¦18±Ç Á¦1È£ 2007 (°øµ¿ ÀúÀÚ)
    3 ADHD ÃʵîÇлýÀ» À§ÇÑ Çб³ Á᫐ »çȸ¼º±â¼ú ÈÆ·Ã ÇÁ·Î±×·¥ÀÇ È¿°ú¿¡ ´ëÇÑ ¿¬±¸, ¼Ò¾ÆÃ»¼Ò³âÁ¤½ÅÀÇÇÐ Á¦20±Ç Á¦2È£ 2009 (°øµ¿ ÀúÀÚ)
    4 ¸¸¼º ƽ Àå¾Ö¿Í Àϰú¼º ƽ Àå¾ÖÀÇ ºñ±³ ¿¬±¸ (ÇÐÀ§ ³í¹®)
    5 CES-D and SCL-90 as screening instruments for depression in young adolescents: a large school-based epidemiological study (ÇØ¿ÜÇÐȸ Æ÷½ºÅÍ ¹ßÇ¥)
    6 Autism and Beauty: Neural Correlates of Aesthetic Experiences in Autism Spectrum Disorder, J Korean Acad Child Adolesc Psychiatry 2018;29(3);101-113 (°øÀúÀÚ)
    7 ÀÚÆó½ºÆåÆ®·³Àå¾Ö ȯÀÚ¿¡¼­ÀÇ ÀÎÁöÀû °ø°¨ ¹× Á¤¼­Àû °ø°¨ÀÇ ½Å°æ »ó°ü¹°, J Korean Acad Child Adolesc Psychiatry 2016;27(3):196-206
¹èÇÏÇö ¿øÀå
¼­¿ïž¸¶À½Å¬¸®´Ð °­ºÏ
¹èÇÏÇö ¿øÀå
  • °æÈñ´ëÇб³ Á¹¾÷
  • ¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ
  • ±¹¸³Á¤½Å°Ç°­¼¾ÅÍ Á¤½Å°Ç°­ÀÇÇаú ·¹Áö´øÆ®
  • ±¹¸³Á¤½Å°Ç°­¼¾ÅÍ ¼Ò¾ÆÃ»¼Ò³âÁ¤½Å°ú ·¹Áö´øÆ®
  • ´ëÇÑ ½Å°æÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø
  • ´ëÇÑ ¼Ò¾ÆÃ»¼Ò³âÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø
  • ´ëÇѺҾÈÀÇÇÐȸ ºÒ¾ÈÀå¾Ö ½ÉÃþÄ¡·á°úÁ¤
  • °­ºÏ±¸ Áßµ¶ÅëÇÕ°ü¸®¼¾ÅÍ ¸¶À½³ª´©±â ÇÁ·Î±×·¥ Á¤½Å°Ç°­°­Á ÁøÇà
  • Àü) ±¤Áø±¸Á¤½Å°Ç°­º¹Áö¼¾ÅÍ »ó´ãÀÇ
  • ¿¬±¸ ¹× ÇмúȰµ¿ ¾ÆÀÌÄÜ
    ¿¬±¸ ¹× ÇмúȰµ¿
    1 Á¶Çöº´ ȯÀÚ¿¡¼­ ºñÀüÇüÇ×Á¤½Åº´¾à¹° »ç¿ë½Ã ´ë»çÁöÇ¥¿¡ ¹ÌÄ¡´Â ¿µÇâ Á¶»ç : 3³â ÃßÀû¿¬±¸
    The Effects on Metabolic Syndrome Parameters of Atypical Antipsychotic Agents in Schizophrenics Patients : 3 Years Retrospective Follow Up
    ¹èÇÏÇö, À±ÇØÁÖ, ¹ÚÀº°æ, ÀÌÁ¾ÀÏ
    Korean Society for Schizophrenia Research Vol. 20. 1, 2017 : 5-14
    2 Á¶Çöº´ ȯÀÚ¿¡¼­ Ç×Á¤½Åº´¾à¹° À¯ÁöÄ¡·á ½Ã Ä¡·á°á°ú¿¡ ´ëÇÑ ¿¬±¸
    A Study on Discontinuation Rate on Maintenance Treatment of Antipsychotic Agents in Schizophrenic Patients
    ¹èÇÏÇö, ³ªÀÇÇö, À±ÇØÁÖ, ¹ÚÀº°æ, ÀÌÁ¾ÀÏ
    Korean Society for Schizophrenia Research Vol. 20. 2, 2017 : 69-76
  • ¿¬±¸ ¹× ÇмúȰµ¿ ¾ÆÀÌÄÜ
    ¿¬±¸ ¹× ÇмúȰµ¿
    1 Gahye Noh, Insun Kwon, Miji Lee, So Hyun Ahn, and Jeong Lan Kim, Factor analysis of delirium in elderly, using the Korean version of Delirium rating scale-revised-98, Psychiatry Investig 2018 April 5 (ÁÖ ÀúÀÚ)
    2 Eunice Seoung, Gahye Noh, Kyung Hwa Lee, Jae-won Kim, Relationship of social and behavioral characteristics to suicidality in Korean adolescents with self-harm (ÇØ¿ÜÇÐȸ Æ÷½ºÅÍ ¹ßÇ¥)
¼³¼øÈ£ ¼ÒÀå
¼­¿ïž¸¶À½Å¬¸®´Ð °­ºÏ
¼³¼øÈ£ ¼ÒÀå
  • ÀÓ»ó½É¸®Àü¹®°¡, »ó´ã½É¸®»ç 1±Þ
  • ¼­¿ï´ëÇб³ ±¹¹®Çаú/½É¸®Çаú Á¹¾÷
  • ¼­¿ï´ëÇб³ »çȸ°úÇдëÇпø ½É¸®Çаú ¼®»ç (ÀÓ»ó»ó´ã½É¸®ÇÐ Àü°ø)
  • ¼­¿ï´ëÇб³ Àǰú´ëÇпø ÀÇÇаú ¹Ú»ç (Á¤½Å°úÇÐ Àü°ø)
  • ¼­¿ï´ëÇк´¿ø ½Å°æÁ¤½Å°ú ÀÓ»ó½É¸®Àü¹®°¡ °úÁ¤ ¼ö·Ã
  • ¼­¿ï´ëÇк´¿ø ½Å°æÁ¤½Å°ú ÀÓ»ó½É¸®Àü¹®°¡
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ Á¤½Å°úÇб³½Ç ¿¬±¸¿ø
  • Çѱ¹½É¸®ÇÐȸ Á¤È¸¿ø
  • Çѱ¹ÀÓ»ó½É¸®ÇÐȸ Àü¹®°¡ ȸ¿ø
  • Çѱ¹»ó´ã½É¸®ÇÐȸ 1±Þ ȸ¿ø
  • Àü) Çѱ¹ÀÓ»ó½É¸®ÇÐȸ Ãѹ«ÀÌ»ç
  • Àü) ¼­¿ï°¡Á¤¹ý¿ø ½É¸®»ó´ãÁ¶»çÀü¹®°¡
  • ¿¬±¸ ¹× ÇмúȰµ¿ ¾ÆÀÌÄÜ
    ¿¬±¸ ¹× ÇмúȰµ¿
    1 Seol SH, Kwon JS, Shin MS. Korean self-report version of the Yale-Brown Obsessive-Compulsive Scale: factor structure, reliability, and validity. Psychiatry Investigation, 2013;10(1):17-25
    2 Seol SH, Kwon JS, Kim YY, Kim SN, Shin MS. Internet-based cognitive behavioral therapy for obsessive-compulsive disorder in Korea. Psychiatry Investigation, 2016;13(4):1-10
    3 º¯Áõ¹ýÀû ÀÎÁöÇൿġ·á. ½Å¹Î¼·, ¹Ú¼¼¶õ, ¼³¼øÈ£, Ȳ¼®Çö ¿ª. ½Ã±×¸¶ÇÁ·¹½º, 2006
    4 °­¹ÚÁõÀÇ ÀÎÁöÄ¡·á-Àü¹®°¡¿ë Áöħ¼­. ½Å¹Î¼·, ¼³¼øÈ£, ±ÇÁؼö ¿ª. ½Ã±×¸¶ÇÁ·¹½º, 2008
    5 °­¹ÚÁõÀÇ ÅëÇÕÀû ÀÌÇØ, ±ÇÁؼö ÆíÀú(¼³¼øÈ£ ¿Ü 20ÀÎ °øÀú). ÇÐÁö»ç, 2009
    6 ÀÌ»ó½É¸®ÇÐ ½Ã¸®Áî-³ë³â±â Á¤½ÅÀå¾Ö. ¼³¼øÈ£, ÀÓ¼±¿µ. ÇÐÁö»ç, 2015
    7 ±àÁ¤ ÀÓ»ó½É¸®ÇÐ ÇÚµåºÏ, ¼³¼øÈ£ ¿Ü 9¸í °ø¿ª, ÇÐÁö»ç, 2022

½É¸®Æò°¡

À̽Âȯ
ÀÓ»ó½É¸®Àü¹®°¡
¾ÆÁÖ´ëÇб³ ½É¸®Çаú
¾ÆÁÖ´ëÇб³ ÀϹݴëÇпø ÀÓ»ó½É¸®ÇÐ Àü°ø
¼­¿ï´ëº´¿ø ¼Ò¾ÆÃ»¼Ò³âÁ¤½Å°ú ÀÓ»ó½É¸®Àü¹®°¡
Â÷»ûº°
Á¤½Åº¸°ÇÀÓ»ó½É¸®»ç 1±Þ
¼­°­´ëÇб³ ½É¸®Çаú
¼­°­´ëÇб³ ÀϹݴëÇпø »ó´ã½É¸® ¹× ÀÓ»óÀü°ø
¼­¿ï¾Æ»êº´¿ø Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó½É¸®Àü¹®°¡
Á¤ÀÚ¸²
ÀÓ»ó½É¸®Àü¹®°¡
¿¬¼¼´ëÇб³ »ý¹°Çаú
Ä«Å縯´ëÇб³ ÀϹݴëÇпø ÀÓ»ó½É¸®Àü°ø
¼­¿ï´ëº´¿ø ¼Ò¾ÆÃ»¼Ò³âÁ¤½Å°ú ÀÓ»ó½É¸®Àü¹®°¡

ÀÎÁöÇнÀÄ¡·á/¹ß´ÞÆò°¡/ÇнÀÆò°¡

¹Ú¼­À±
¼º±Õ°ü´ëÇб³´ëÇпø ¾Æµ¿Ã»¼Ò³âÇаú Àü°ø
¼º±Õ°ü´ëÇб³ ÀϹݴëÇпø ¾Æµ¿Ã»¼Ò³âÇаú(¹Ú»ç¼ö·á)
Ȳº¸¶÷
Ä«Å縯´ëÇб³ ½É¸®Çаú Á¹¾÷
ÀÌÈ­¿©ÀÚ´ëÇб³ ´ëÇпø ½É¸®Çаú ¹ß´ÞÀÓ»ó Àü°ø

¾ð¾îÄ¡·á

ÀÌ´Ù¿ø
ÇѸ²´ëÇб³ ¾ð¾îº´¸®Çаú
ÀÌÈ­¿©ÀÚ´ëÇб³ ´ëÇпø ¾ð¾îº´¸®Çаú Àü°ø
¾ð¾îÀçȰ»ç 1±Þ
À±¼Ò¸Á
°Ç±¹´ëÇб³ ¿µ¾î¿µ¹®Çаú
ÀÌÈ­¿©ÀÚ´ëÇб³ ´ëÇпø ¾ð¾îº´¸®Çаú Àü°ø
¾ð¾îÀçȰ»ç 2±Þ
Á¶Çý·Ã
´Ü±¹´ëÇб³ ÀϾîÀϹ®Çаú
ÀÌÈ­¿©ÀÚ´ëÇб³ ´ëÇпø ¾ð¾îº´¸®Çаú Àü°ø
¾ð¾îÀçȰ»ç 1±Þ

³îÀÌÄ¡·á/¹ß´Þ³îÀÌ/ºÎ¸ð±³À°/³îÀÌÆò°¡

Àü¿¬Èñ
¼­¿ï¿©ÀÚ´ëÇб³ ´ëÇпø Ç¥Çö¿¹¼úÄ¡·áÇаú Àü°ø
Á¤ÁøÈñ
¼º±Õ°ü´ëÇб³ ´ëÇпø ¾Æµ¿ÀÓ»ó ¹× »ó´ãÀü°ø(¹Ú»ç¼ö·á)
½É¿¹³ª
¼÷¸í¿©ÀÚ´ëÇб³ ´ëÇпø ¾Æµ¿½É¸®Ä¡·á Àü°ø
½Å¼±¹Ì
¼÷¸í¿©ÀÚ´ëÇб³ ´ëÇпø ¾Æµ¿½É¸®Ä¡·á Àü°ø
±è¹Î°æ
¸íÁö´ëÇб³ ´ëÇпø ¿¹¼ú½É¸®Ä¡·áÇаú Àü°ø
ÇѾç´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¾Æµ¿½É¸®Ä¡·áÇаú ¹Ú»ç°úÁ¤
ÇüÀ±Á¤
¸íÁö´ëÇб³ ´ëÇпø ¾Æµ¿ ½É¸®Ä¡·áÇаú Àü°ø

û¼Ò³â »ó´ãÄ¡·á/¹Ì¼úÄ¡·á

ÃÖ°¡¿µ
¼­¿ï¿©ÀÚ´ëÇб³ ´ëÇпø Ç¥Çö¿¹¼úÄ¡·áÇаú Àü°ø
¹ÚÈñ½Â
¼­¿ï¿©ÀÚ´ëÇб³ ´ëÇпø Ç¥Çö¿¹¼úÄ¡·áÇаú Àü°ø
À̼ҹÌ
Áß¾Ó´ëÇб³ ½É¸®Çаú
Áß¾Ó´ëÇб³´ëÇпø ÀÓ»ó½É¸®ÇÐÀü°ø
°í·Á´ëÇб³´ëÇпø »ó´ã½É¸®±³À°Àü°ø
ÀÓ»ó½É¸®Àü¹®°¡

»ó´ãÄ¡·á

±è¼³È­
´ö¼º¿©ÀÚ´ëÇб³ ÀϹݴëÇпø »ó´ã ¹× ÀÓ»ó½É¸®ÇÐ Àü°ø
À̼ҹÌ
Áß¾Ó´ëÇб³ ½É¸®Çаú
Áß¾Ó´ëÇб³´ëÇпø ÀÓ»ó½É¸®ÇÐÀü°ø
°í·Á´ëÇб³´ëÇпø »ó´ã½É¸®±³À°Àü°ø
ÀÓ»ó½É¸®Àü¹®°¡

»çȸ¼º ÁõÁø ÇÁ·Î±×·¥

¹Ú¼­À±
¼º±Õ°ü´ëÇб³ ´ëÇпø ¾Æµ¿Ã»¼Ò³âÇаú Àü°ø
¼º±Õ°ü´ëÇб³ ÀϹݴëÇпø ¾Æµ¿Ã»¼Ò³âÇаú(¹Ú»ç¼ö·á)